webinar register page

Navigating germline vs. somatic testing in cancer care: A multi-disciplinary panel discussion
Kate Reed, M.P.H., Sc.M., CGC, Director, Precision Oncology Education, Clinical Education Program, The Jackson Laboratory
Nick Renzette, Ph.D., Supervision, Clinical Data Analysis & Reporting, The Jackson Laboratory
Stephanie Sharp, M.S., CGC, Genetic Counselor, Cancer Risk and Prevention Clinic, Maine Medical Center
Christine Walko, Pharm.D., BCOP, FCCP, Associate Member, Individualized Cancer Management, Moffitt Cancer Center

Event Description

Genomic tumor testing performed for treatment decision-making may also identify variants associated with hereditary cancer risk. However, interpreting possible hereditary or germline risks based on genomic tumor testing can be challenging. In this educational webinar, a multidisciplinary panel of clinical and laboratory experts will discuss case studies that highlight factors relevant for the interpretation of tumor results for hereditary risks.

The Jackson Laboratory is a non-profit biomedical research organization and National Cancer Institute-designated Cancer Center.

Jun 9, 2022 12:00 PM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Clinical Education at JAX.